You have 9 free searches left this month | for more free features.

gsk2251052

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Infections, Urinary Tract Trial in Worldwide (GSK2251052, imipenem-cilastatin, Placebo)

Terminated
  • Infections, Urinary Tract
  • GSK2251052
  • +2 more
  • Los Angeles, California
  • +23 more
Aug 9, 2017

Community-acquired Infection Trial in Minneapolis (GSK2251052)

Completed
  • Community-acquired Infection
  • GSK2251052
  • Minneapolis, Minnesota
    GSK Investigational Site
Jul 5, 2017

Community-acquired Infection Trial in Adelaide (GSK2251052)

Terminated
  • Community-acquired Infection
  • GSK2251052
  • Adelaide, South Australia, Australia
    GSK Investigational Site
Jun 27, 2017

Infections, Bacterial Trial in Adelaide (GSK2251052, Placebo)

Completed
  • Infections, Bacterial
  • GSK2251052
  • Placebo
  • Adelaide, South Australia, Australia
    GSK Investigational Site
Jun 27, 2017